SYNB-8802
- Generic Name
- SYNB-8802
Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel Syndrome
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2023-03-17
- Lead Sponsor
- Synlogic
- Target Recruit Count
- 11
- Registration Number
- NCT05377112
- Locations
- 🇺🇸
PPD, part of Thermo Fisher Scientific, Austin, Texas, United States
Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria
- First Posted Date
- 2020-11-16
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Synlogic
- Target Recruit Count
- 77
- Registration Number
- NCT04629170
- Locations
- 🇺🇸
Genesis Clinical Research, Tampa, Florida, United States
🇺🇸PRA Health Sciences, Salt Lake City, Utah, United States
🇺🇸Urological Associates of Southern Arizona (open to remote participation), Tucson, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath